Search

Piramal Enterprises

Sector: Healthcare | Industry: Drugs & Pharma
R 1,556.85 88.00  | 5.99% -25.82% 15.53 30,947.48
NSE Price: Oct 18, 15:58 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 18, 15:58 1,556.85 88.00 5.99% 1,460.00 1,468.85 2,854,853 1,443.00 - 1,577.40
BSE Oct 18, 2019 1,556.35 88.40 6.02% 1,467.95 1,467.95 138,450 1,443.25 - 1,577.30
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
TTM Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Income StatementR Cr
Operating Revenue13,819.1013,215.3410,631.038,503.656,341.51 5,122.614,502.74
Other Income311.24317.34264.10233.75251.66 254.75225.43
Total Income14,130.3413,532.6810,895.138,737.406,593.17 5,377.364,728.17
Total Expenditure6,091.326,125.285,475.735,004.504,649.26 4,237.693,867.83
Operating Profit8,039.027,407.405,419.403,732.901,943.91 1,139.67860.34
Interest4,909.154,409.742,978.302,030.98974.08 510.601,049.58
PBDT3,129.872,997.662,441.101,701.92969.83 629.07-189.24
Depreciation549.57520.15477.33381.70255.45 289.87246.90
PBT & Exceptional Items2,580.302,477.511,963.771,320.22714.38 339.20-436.14
Exceptional Items-24.71-465.64--9.9645.66 2,696.151.37
Profit before Tax2,555.592,011.871,963.771,310.26760.04 3,035.35-434.77
Provision for Tax897.67861.13-2,876.42228.1249.51 344.9662.75
Profit after Tax1,657.921,150.744,840.191,082.14710.53 2,690.39-497.52
Minority Interest2.962.971.210.29- 0.29-0.76
Share of Associate332.04319.38280.09169.90194.21 159.27-3.13
Consolidated Profit1,992.921,473.095,121.491,252.33904.74 2,849.95-501.41
 
LiabilitiesR Cr
Share Capital36.8936.8936.0534.5134.51 34.5134.51
Total Reserves27,211.9627,211.9626,526.3414,848.0612,913.84 11,701.429,286.55
Shareholder's Funds27,253.0327,253.0326,562.3914,882.5712,948.35 11,735.939,321.06
Minority Interest9.039.0312.0013.210.12 29.11-
Long Term Borrowings27,019.6227,019.6224,220.6114,495.697,474.00 3,787.482,679.60
Other Non Current Liabilities263.426,049.145,350.024,874.744,573.18 4,056.434,071.21
Current Liabilities31,080.9831,210.2922,478.7318,962.2810,542.27 5,694.059,490.09
Total Debt*-56,023.2644,160.8030,450.9816,278.79 7,306.109,551.90
Total Liabilities85,626.0891,541.1178,623.7553,228.4935,537.92 25,303.0025,561.96
 
AssetsR Cr
Net Block5,511.8511,196.7010,725.539,972.707,525.28 7,065.236,191.00
Non Current Investments23,299.4723,299.4723,643.6221,716.6615,682.30 6,820.889,249.93
Other Non-Current Assets44,540.5344,641.4031,688.9412,375.727,675.40 6,052.655,749.37
Current Investments2,447.652,447.655,198.533,463.95634.40 947.01195.85
Cash and Bank917.51917.512,467.011,540.90365.94 460.08333.60
Other Current Assets8,909.079,038.384,900.124,158.563,654.60 3,957.153,842.21
Net Current Assets-18,806.75-18,806.75-9,913.07-9,798.87-5,887.33 -329.81-5,118.43
Miscellaneous Exp. Not Written Off----- --
Total Assets85,626.0891,541.1178,623.7553,228.4935,537.92 25,303.0025,561.96
 
Cash FlowR Cr
From Operations--11,597.46-15,966.59-10,056.65-6,956.19 -2,206.85-1,604.43
From Investing Activities--826.51-1,767.73-2,402.84-604.04 6,177.071,482.91
From Finance Activities-10,752.4818,650.2513,570.467,543.90 -3,864.63125.84
Net Inflow/Outflow--1,671.49915.931,110.97-16.33 105.594.32
 
Key Ratios
Adjusted EPS (Rs)100.2279.86284.1372.1652.13 164.21-28.89
Adjusted Book Value (Rs)1,583.781,477.301,473.64857.49746.05 676.19537.05
Dividend per Share (Rs)-28.0025.0021.0017.50 20.0052.50
Cash Flow per Share (Rs)--628.76-885.80-582.83-403.14 -127.90-92.98
Debt to Equity0.992.061.662.051.26 0.621.02
Current Ratio0.390.400.560.480.44 0.940.46
ROCE (%)-8.348.528.967.19 18.703.30
RONW (%)6.174.2823.367.785.76 25.55-4.96
Operating Margin (%)58.1756.0550.9843.9030.65 22.2519.11
Net Margin (%)11.738.5044.4312.3910.78 50.03-10.52
Revenue Growth (%)22.4324.3125.0234.1023.79 13.7727.91
Net Profit Growth (%)-62.85-76.23347.2852.30-73.59 640.76-128.77
EPS Growth (%)-59.69-71.89293.7838.42-68.25 668.39-120.60
Book Value Growth (%)-2.5878.4814.9410.33 25.91-13.08
 
Market Cues
Close Price (Rs)1,556.852,763.252,432.851,891.961,030.41 865.88545.30
High Price (Rs)2,787.703,307.953,070.952,084.781,061.73 942.48645.62
Low Price (Rs)1,316.001,794.901,887.981,018.48799.32 517.27467.26
Market Cap (Rs Cr)30,947.4850,810.4443,990.0132,822.4617,877.04 14,994.609,401.39
Price / Earnings15.5334.498.5926.2119.76 5.260.00
Price / Book Value0.981.861.662.211.38 1.281.01
Dividend Yield (%)1.801.021.021.101.69 2.309.64
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
Essential checks
Altman Z-Score
0.88
Piotroski F-Score
2
Modified C-Score
2
5-Years Price to Earnings
15.53
5-Years Price to Book
0.98
Earnings Yield
EBIT / Enterprise value
8.93%
PEG
Price / Earnings to growth ratio
-1.95
Related Stocks
  Current Price   Chng %
Abbott India R10,704.50 -2.55%
Alkem Laboratories R1,958.95 +2.09%
Biocon R259.45 +0.54%
Cadila Healthcare R240.65 +1.20%
Cipla R444.15 -0.48%
Glaxosmithkline Pharma R1,438.70 -0.10%
Lupin R739.10 +1.73%
Pfizer R3,221.95 +0.82%
Sanofi India R5,996.25 -0.93%
Torrent Pharmaceuticals R1,684.65 -0.58%
As on Oct 18, 15:59